20 types of vitamins disease system all ages group disease treatment investigation finding differential diagnosis contraindications ICU and OPD and blood RBC WBC platelet nutrition flute of diagnosis summary
Sources: Andrews' Diseases of the Skin; Fitzpatrick's Dermatology; Lippincott's Biochemistry; Robbins & Kumar Basic Pathology; Bradley & Daroff's Neurology; Washington Manual of Medical Therapeutics; Henry's Clinical Diagnosis & Lab Methods; Tietz Textbook of Laboratory Medicine
| Feature | Details |
|---|---|
| Disease Name | Beriberi (dry/wet/cerebral); Wernicke-Korsakoff Syndrome |
| Age Group | All ages; especially infants (breast-fed from deficient mothers), adults with alcoholism, post-bariatric surgery patients, ICU patients |
| System | Neurological, Cardiovascular, Cutaneous |
| Key Findings | Dry beriberi: peripheral neuropathy, muscle wasting, paresthesias; Wet beriberi: dilated cardiomyopathy, high-output cardiac failure, pitting edema; Wernicke: confusion, ataxia, ophthalmoplegia (triad); Korsakoff: anterograde amnesia, confabulation |
| Cutaneous | Edema, red burning tongue |
| Investigations | Serum thiamine levels (↓); RBC transketolase activity (↓); erythrocyte thiamine pyrophosphate effect (ETPPE >25% = deficient); Blood lactate (↑ in acute); ABG; ECG (cardiomegaly, sinus tachycardia); MRI brain (Wernicke: mammillary body signal change) |
| Blood Findings | RBC: normocytic anemia (sometimes); Lactic acidosis; WBC: usually normal; Platelets: normal |
| Differential Diagnosis | Alcoholic cardiomyopathy; Guillain-Barré; viral encephalitis; Korsakoff vs other amnestic syndromes; diabetic neuropathy |
| Treatment — OPD | Oral thiamine 100 mg/day × 4 weeks; dietary correction (whole grains, legumes, meat) |
| Treatment — ICU | IV thiamine 100–500 mg TDS × 3–5 days BEFORE any dextrose (critical! giving glucose without thiamine can precipitate Wernicke); NG/parenteral nutrition supplementation |
| Contraindications | Never administer IV dextrose to nutritionally depleted patients WITHOUT thiamine cover first |
| Nutrition Clue | Polished white rice diet, alcoholism, hyperemesis gravidarum, prolonged IV therapy without supplementation |
| Summary | Life-threatening in ICU; Wernicke is a medical emergency — empirically treat with thiamine before glucose |
| Feature | Details |
|---|---|
| Disease Name | Ariboflavinosis |
| Age Group | Children in developing countries; adults with malnutrition, alcoholism, malabsorption |
| System | Mucocutaneous, Ocular |
| Key Findings | Cheilitis (cracking at mouth corners = angular stomatitis), glossitis (magenta tongue), seborrheic dermatitis, photophobia, corneal vascularization, scrotal/vulval dermatitis |
| Investigations | RBC glutathione reductase activity coefficient (EGRAC >1.4 = deficient); plasma/urine riboflavin levels |
| Blood Findings | Normocytic or normochromic anemia; WBC/platelets usually normal |
| Differential Diagnosis | Iron deficiency (angular stomatitis), pellagra, contact dermatitis, herpes labialis |
| Treatment — OPD | Riboflavin 5–10 mg/day PO; dietary sources: milk, eggs, liver, leafy greens |
| Treatment — ICU | IV/parenteral supplementation in multivitamin infusions; riboflavin 10–20 mg/day IV |
| Contraindications | Phenothiazines and tricyclic antidepressants reduce riboflavin absorption |
| Nutrition Clue | Vegan diet without supplementation; anorexia nervosa |
| Summary | Rarely life-threatening; OPD condition; oral replacement resolves within weeks |
| Feature | Details |
|---|---|
| Disease Name | Pellagra |
| Age Group | All ages; endemic in maize-dependent populations; alcoholics; Hartnup disease (children) |
| System | Dermatological, GI, Neurological (3 Ds + Death = 4 Ds) |
| Key Findings | 3 Ds: Dermatitis (Casal's necklace – photosensitive rash on sun-exposed areas), Diarrhea, Dementia; rash is bilaterally symmetrical; hyperpigmentation, scaling on dorsa of hands/feet/neck |
| Investigations | Urinary N-methylnicotinamide (↓); plasma niacin; blood B6 levels (co-deficiency common); LFTs; urine for Hartnup amino acids |
| Blood Findings | Normocytic anemia; WBC/platelets normal; may have ↑ homocysteine |
| Differential Diagnosis | Photodermatitis, SLE butterfly rash, pellagra-like drug reactions (isoniazid, pyrazinamide, 5-fluorouracil), porphyria cutanea tarda, Hartnup disease |
| Treatment — OPD | Nicotinamide (niacinamide) 100 mg PO TDS × 3–4 weeks; nicotinic acid 50 mg TDS; high-dose niacin used for hyperlipidemia (separate indication) |
| Treatment — ICU | Niacinamide IV/IM 100 mg q6h; nutritional rehabilitation; treat underlying cause |
| Contraindications | High-dose nicotinic acid: flushing, hepatotoxicity, hyperglycemia, gout; avoid in active peptic ulcer; use niacinamide form (no flushing) for deficiency |
| Nutrition Clue | Corn (maize)-based diet (lacks tryptophan), isoniazid therapy, alcohol excess |
| Summary | OPD management mostly; ICU if severe dementia or GI complications; niacinamide is first-line |
| Feature | Details |
|---|---|
| Disease Name | Pantothenic acid deficiency (rare); Burning Feet Syndrome |
| Age Group | All ages; prisoners of war (historically); severe malnutrition |
| System | Neurological, Metabolic |
| Key Findings | Burning/tingling of feet, fatigue, headache, insomnia, GI disturbance, paresthesias; adrenal insufficiency in severe cases |
| Investigations | Whole blood or plasma pantothenate (↓); no routine clinical test widely available |
| Blood Findings | Normal CBC typically |
| Differential Diagnosis | Diabetic neuropathy, B12 deficiency neuropathy, carpal tunnel, erythromelalgia |
| Treatment | Pantothenic acid 5–10 mg/day PO (RDA: 5 mg/day); found in virtually all foods |
| Contraindications | Very rare; generally well tolerated |
| Summary | Extremely rare in clinical practice; isolated deficiency almost never seen |
| Feature | Details |
|---|---|
| Disease Name | Pyridoxine (B6) deficiency |
| Age Group | Infants (seizures), adults on isoniazid/oral contraceptives/penicillamine |
| System | Neurological, Haematological, Mucocutaneous |
| Key Findings | Glossitis, angular stomatitis, seborrheic dermatitis, peripheral sensory neuropathy; infant seizures (refractory); sideroblastic anemia |
| Investigations | Plasma pyridoxal-5-phosphate (PLP) levels (↓ <30 nmol/L); urine xanthurenate (↑ after tryptophan load); CBC; iron studies; EEG in infants |
| Blood Findings | RBC: sideroblastic anemia (hypochromic, microcytic, ring sideroblasts on Perls' stain in bone marrow); WBC: normal; Platelets: normal |
| Differential Diagnosis | Iron deficiency anemia, lead poisoning, thalassemia, niacin deficiency; infant seizures vs other causes |
| Treatment — OPD | Pyridoxine 50–100 mg/day PO; isoniazid-associated: give 25–50 mg/day prophylactically |
| Treatment — ICU | IV pyridoxine 100 mg stat for seizures; repeat dosing |
| Contraindications | High-dose pyridoxine (>500 mg/day chronic) causes sensory neuropathy (paradoxical toxicity); avoid in Parkinson's patients on levodopa (B6 reduces levodopa efficacy) |
| Nutrition Clue | Isoniazid TB treatment, oral contraceptive pill, alcoholism, dialysis patients |
| Summary | Isoniazid prophylaxis must always include B6; sensory neuropathy at both deficiency and toxicity ends |
| Feature | Details |
|---|---|
| Disease Name | Biotin deficiency; Biotinidase deficiency (inherited) |
| Age Group | Infants (biotinidase deficiency), adults on raw egg diet, prolonged TPN |
| System | Mucocutaneous, Neurological, Metabolic |
| Key Findings | Alopecia, seborrheic dermatitis, periorificial rash (around eyes/nose/mouth), conjunctivitis, ataxia, hypotonia, lactic acidosis |
| Investigations | Plasma/urine biotin; organic acids in urine (↑ 3-hydroxyisovaleric acid); biotinidase enzyme activity (neonatal screening); ammonia levels; blood glucose |
| Blood Findings | Normal CBC; metabolic acidosis; ↑ lactate; ↑ ammonia |
| Differential Diagnosis | Zinc deficiency (similar rash), acrodermatitis enteropathica, seborrheic dermatitis, multiple carboxylase deficiency |
| Treatment | Biotin 5–10 mg/day PO (pharmacologic dose); biotinidase deficiency: lifelong biotin 5–20 mg/day |
| Contraindications | High biotin doses (>10 mg/day) interfere with troponin, TSH, free T4 immunoassay results — must disclose biotin use before cardiac or thyroid testing |
| Nutrition Clue | Raw egg whites (avidin protein binds biotin, preventing absorption); prolonged TPN without biotin; anticonvulsant use |
| Summary | Biotinidase deficiency caught on neonatal screen; raw egg white consumption is classic clinical scenario |
| Feature | Details |
|---|---|
| Disease Name | Folic acid deficiency; Megaloblastic anemia; Neural tube defects |
| Age Group | Infants, pregnant women (neural tube defects), elderly, alcoholics |
| System | Haematological, Neurological (fetus), Mucocutaneous |
| Key Findings | Megaloblastic anemia (macrocytic), glossitis, cheilitis, diffuse hyperpigmentation; neural tube defects (spina bifida, anencephaly) in fetus; NO neurological symptoms in adults (contrast with B12) |
| Investigations | Serum folate (↓ <3 ng/mL); RBC folate (↓ <140 ng/mL — better indicator of stores); homocysteine (↑); MCV (↑ >100 fL); peripheral blood film: hypersegmented neutrophils, macro-ovalocytes; bone marrow: hypercellular with megaloblasts; exclude B12 deficiency first |
| Blood Findings | RBC: macrocytic, macro-ovalocytes, anemia (↓ Hb); WBC: hypersegmented neutrophils (5+ lobes); Platelets: ↓ (thrombocytopenia) in severe; pancytopenia possible |
| Differential Diagnosis | Vitamin B12 deficiency (clinically identical — CRITICAL distinction: B12 causes subacute combined degeneration of cord; folate does NOT); hypothyroidism, liver disease, drug-induced megaloblastosis (methotrexate, hydroxyurea, trimethoprim) |
| Treatment — OPD | Folic acid 5 mg/day PO × 4 months; pregnancy prevention: 400 mcg/day preconceptionally and for first 12 weeks; high-risk (previous NTD): 5 mg/day |
| Treatment — ICU | IV folic acid if NPO; correct precipitating causes; blood transfusion if Hb critically low |
| Contraindications | Never treat with folate alone without ruling out B12 deficiency — folate corrects anemia but worsens/unmasks neurological damage of B12 deficiency |
| Nutrition Clue | Alcohol, poor green vegetable intake, pregnancy demands, methotrexate, phenytoin (↓ absorption) |
| Summary | Pre-pregnancy folate supplementation prevents NTDs; always check B12 before treating megaloblastic anemia with folate alone |
| Feature | Details |
|---|---|
| Disease Name | Pernicious anemia; Subacute combined degeneration of spinal cord; B12 deficiency neuropathy |
| Age Group | Adults >50 (pernicious anemia); vegans; post-gastrectomy; ileal disease patients; metformin users |
| System | Haematological, Neurological, Mucocutaneous |
| Key Findings | Megaloblastic anemia; subacute combined degeneration (dorsal + lateral column demyelination → spastic paraparesis, ↓ vibration/proprioception, positive Romberg); glossitis; hyperpigmentation (resembles Addison); canities (premature grey hair); dementia; psychiatric symptoms |
| Investigations | Serum B12 (↓ <200 pg/mL); methylmalonic acid (MMA) ↑ (most sensitive); homocysteine ↑; MCV ↑; peripheral blood film: macro-ovalocytes, hypersegmented neutrophils; anti-intrinsic factor antibodies (pernicious anemia); Schilling test (malabsorption); MRI spine (posterior/lateral column signal); gastric achlorhydria |
| Blood Findings | RBC: macrocytic anemia, macro-ovalocytes; ↓ Hb; WBC: hypersegmented neutrophils (≥1 neutrophil with 6 lobes OR ≥5% with 5 lobes); Platelets: ↓ in severe; Pancytopenia; ↑ LDH; ↑ bilirubin (ineffective erythropoiesis) |
| Differential Diagnosis | Folate deficiency; hypothyroidism; liver disease; myelodysplastic syndrome; MS (spinal cord demyelination); copper deficiency neuropathy; HIV myelopathy |
| Treatment — OPD | IM hydroxocobalamin 1 mg on alternate days × 2 weeks, then 1 mg every 3 months (lifelong if pernicious anemia); high-dose oral B12 1–2 mg/day (works by passive diffusion even without intrinsic factor) |
| Treatment — ICU | IM/IV B12 1 mg/day; supportive care for severe anemia (transfuse if Hb <7 g/dL); neurological monitoring |
| Contraindications | High doses generally safe; avoid correcting anemia rapidly in elderly (risk of cardiac overload); folate supplementation alone is contraindicated (masks anemia, worsens neuro) |
| Nutrition Clue | Vegan diet, strict vegetarian, post-gastrectomy, metformin, long-term antacid/PPI use, H. pylori eradication therapy, Crohn's (terminal ileum involvement) |
| Summary | MMA is most sensitive test; neurological damage may be irreversible — diagnose and treat early; pernicious anemia requires lifelong IM therapy |
| Feature | Details |
|---|---|
| Disease Name | Scurvy |
| Age Group | Elderly males (especially alcoholics), children on restrictive diets, autism spectrum disorder (restricted eating), dialysis patients, chemotherapy patients |
| System | Vascular/Connective tissue, Haematological, Mucocutaneous, Musculoskeletal |
| Key Findings | "4 Hs": Hemorrhagic signs (perifollicular petechiae — pathognomonic), Hyperkeratosis of hair follicles, Hypochondriasis, Hematologic abnormalities; "Corkscrew hairs" in follicles; hemorrhagic gingivitis; ecchymoses (especially lower limbs); subperiosteal hemorrhage (bone pain, pseudoparalysis in children); woody edema; delayed wound healing; epistaxis; depression |
| Investigations | Plasma vitamin C (↓ <11 μmol/L); dietary history; biopsy: follicular hyperkeratosis, coiled hairs, perifollicular hemorrhage (NO vasculitis); X-ray: Frankel line, Trümmerfeld zone, Pelkan spurs, Wimberger sign (children); INR/PT: usually normal; capillary fragility test |
| Blood Findings | RBC: normocytic anemia (blood loss + possible folate co-deficiency); microcytic if iron deficient; WBC: normal; Platelets: normal; coagulation studies: normal (collagen defect, not clotting factor defect) |
| Differential Diagnosis | Vasculitis (HSP/Henoch-Schönlein), thrombocytopenic purpura (ITP), child abuse (in children with bone pain/bruising), leukemia, nutritional rickets, septicemia |
| Treatment — OPD | Ascorbic acid 1000 mg/day × 1 week, then maintenance 100 mg/day; dietary sources: citrus fruits, strawberries, kiwi, peppers; symptom improvement in days |
| Treatment — ICU | IV vitamin C (especially in critically ill, burn patients, sepsis — high-dose IV ascorbic acid being studied); parenteral nutrition with C supplementation; address underlying malnutrition |
| Contraindications | High-dose vitamin C (>1 g/day): oxalate kidney stones risk; hemolysis in G6PD deficiency; caution in hemochromatosis (vitamin C increases iron absorption) |
| Nutrition Clue | Restrictive diet, alcohol, elderly living alone, food insecurity, autism/behavioral restrictive eating |
| Summary | OPD diagnosis; clinical diagnosis confirmed by response to treatment; vasculitis is the most common misdiagnosis |
| Feature | Details |
|---|---|
| Disease Name | Vitamin A Deficiency (VAD); Xerophthalmia; Night blindness |
| Age Group | Children (most common cause of preventable blindness worldwide per WHO); pregnant/lactating women; fat malabsorption patients |
| System | Ophthalmologic, Immunologic, Mucocutaneous |
| Key Findings | Ocular (progression): Night blindness (earliest) → xerophthalmia → Bitot spots (white foamy patches on bulbar conjunctiva) → corneal xerosis → corneal ulceration/keratomalacia → blindness; Cutaneous: Phrynoderma ("toad skin") — keratotic follicular papules on anterolateral thighs/posterolateral arms; xerosis; squamous metaplasia of mucosae; impaired immune function (↑ infection susceptibility) |
| Investigations | Serum retinol (↓ <20 μg/dL; normal 20–50 μg/dL); dark adaptometry; slit-lamp exam; liver function (storage site); fat absorption tests; relative dose response (RDR) test |
| Blood Findings | RBC: normocytic anemia (↓ iron mobilization); WBC: lymphopenia (immune dysfunction); Platelets: normal |
| Differential Diagnosis | Zinc deficiency (also causes night blindness), retinitis pigmentosa, Sjögren syndrome (dry eyes), X-linked retinoschisis |
| Treatment — OPD | WHO protocol: Oral vitamin A 200,000 IU on days 1, 2, and 14 (children 6 months–5 years); 100,000 IU for infants 6–11 months; prophylaxis every 4–6 months in endemic areas |
| Treatment — ICU | IV vitamin A if malabsorption or critically ill; treat concurrent infections; nutritional support |
| Contraindications / Toxicity | Hypervitaminosis A (teratogenic): pseudotumor cerebri, hepatotoxicity, bone pain, alopecia; isotretinoin is a vitamin A analogue — absolutely contraindicated in pregnancy; β-carotene (provitamin A) not acutely toxic |
| Nutrition Clue | Liver, egg yolk, dairy, orange/yellow vegetables (β-carotene); fat malabsorption (celiac, Crohn's, cystic fibrosis, cholestatic liver disease) |
| Summary | #1 preventable blindness cause in children globally; fat-soluble so both deficiency and toxicity are clinically important |
| Feature | Details |
|---|---|
| Disease Name | Nutritional Rickets (children); Osteomalacia (adults); Renal osteodystrophy |
| Age Group | Infants/children: rickets; Adults: osteomalacia; Elderly: osteoporosis-osteomalacia overlap |
| System | Musculoskeletal, Endocrine/Metabolic, Renal |
| Key Findings | Rickets: bowing of legs (genu varum/valgum), rachitic rosary (costochondral beading), Harrison sulcus, craniotabes (ping-pong skull), delayed fontanelle closure, dental enamel defects, growth retardation; Osteomalacia: diffuse bone pain, proximal muscle weakness, waddling gait, fractures; Hypocalcemia signs: tetany, Chvostek sign, Trousseau sign, seizures |
| Investigations | 25-OH vitamin D (↓ <20 ng/mL deficient; <12 ng/mL severe); serum Ca (↓); PO4 (↓); ALP (↑); PTH (↑); X-ray: Looser zones (Milkman fractures) in osteomalacia; cupping/fraying of metaphyses in rickets; bone densitometry (DEXA); 24-h urine calcium (↓) |
| Blood Findings | RBC: usually normal; Ca ↓; PO4 ↓; ALP ↑; PTH ↑; WBC/platelets normal |
| Differential Diagnosis | Hyperparathyroidism, Paget's disease, osteoporosis (normal ALP), X-linked hypophosphatemic rickets (resistant to vitamin D), renal tubular acidosis, fluorosis |
| Treatment — OPD | Adults: Cholecalciferol (D3) 800–2000 IU/day for 3 months, then maintenance; severe deficiency: 50,000 IU/week × 8–12 weeks; children: 400–1000 IU/day; sunlight exposure |
| Treatment — ICU | IV calcium gluconate for hypocalcemic tetany; calcitriol 0.25–0.5 mcg/day for renal osteodystrophy; nutritional support |
| Contraindications / Toxicity | Hypercalcemia (toxicity): hypercalciuria, nephrocalcinosis, nephrolithiasis, metastatic calcification; avoid in hypercalcemia, granulomatous disease (sarcoidosis, TB — ↑ 1α-hydroxylase activity), primary hyperparathyroidism; sunscreen and dark skin ↓ synthesis |
| Nutrition Clue | Breastfed infants (breast milk low in D3), elderly housebound, dark-skinned individuals in northern latitudes, chronic kidney disease, fat malabsorption |
| Summary | Most prevalent micronutrient deficiency globally; check 25-OH D level (not 1,25-OH which may be normal); RDA 600–800 IU (age-dependent) |
| Feature | Details |
|---|---|
| Disease Name | Vitamin E deficiency; Ataxia with Vitamin E Deficiency (AVED) |
| Age Group | Rare; fat malabsorption patients, premature neonates; abetalipoproteinemia (children); AVED (inherited, young adults) |
| System | Neurological (primarily), Haematological |
| Key Findings | Spinocerebellar ataxia, peripheral neuropathy (↓ deep tendon reflexes), ophthalmoplegia, proprioceptive loss, dysarthria; in premature infants: haemolytic anemia, retinopathy |
| Investigations | Serum alpha-tocopherol (↓ <5 mg/L); lipid profile (must interpret relative to total lipid levels); neurophysiology (absent sensory potentials); MRI: posterior column degeneration; gene testing (TTPA mutation in AVED); abetalipoproteinemia workup (lipid profile, blood film — acanthocytes) |
| Blood Findings | RBC: hemolytic anemia (premature infants — oxidative RBC damage); Acanthocytes on smear in abetalipoproteinemia; WBC/platelets: usually normal |
| Differential Diagnosis | Friedreich's ataxia (also posterior column disease), spinocerebellar ataxias, B12 deficiency, MS |
| Treatment — OPD | Alpha-tocopherol 400–800 IU/day PO; malabsorption: water-miscible forms or high-dose fat-soluble up to 1000 mg/day; AVED: 1500–2000 IU/day lifelong |
| Treatment — ICU | Parenteral vitamin E in TPN for premature neonates; address malabsorption |
| Contraindications / Toxicity | High-dose (>400 IU/day) may increase all-cause mortality in some studies; anti-coagulant effect at high doses — caution with warfarin; supplementation NOT established as beneficial in controlled trials for cardiac/cancer prevention |
| Nutrition Clue | Nuts, seeds, vegetable oils, green leafy vegetables; fat malabsorption is the main clinical cause |
| Summary | Isolated dietary deficiency is very rare; clinical disease almost always indicates fat malabsorption or genetic disorder |
| Feature | Details |
|---|---|
| Disease Name | Vitamin K deficiency bleeding (VKDB); Hemorrhagic Disease of the Newborn |
| Age Group | Newborns (critical — standard IM K at birth); adults with malabsorption, antibiotic therapy, liver disease, eating disorders |
| System | Coagulation, Cardiovascular, Skeletal (role in osteocalcin) |
| Key Findings | Purpura, ecchymosis, hemorrhage; newborns: intracranial hemorrhage, GI bleeding, umbilical stump bleeding; coumarin skin necrosis (paradoxical mechanism); adults: bruising, mucous membrane bleeding, haematuria, haematemesis |
| Investigations | PT/INR (↑ — first to rise, as Factor VII has shortest half-life); aPTT (↑); PIVKA-II (protein induced by vitamin K absence — sensitive marker); factors II, VII, IX, X levels (↓); platelets and fibrinogen: NORMAL (distinguishes from DIC) |
| Blood Findings | RBC: normocytic anemia (from blood loss); WBC: normal; Platelets: NORMAL (key feature); PT/INR ↑; aPTT ↑; Factors II, VII, IX, X ↓ |
| Differential Diagnosis | DIC (thrombocytopenia + ↑ D-dimer); liver disease (similar clotting pattern but with thrombocytopenia); hemophilia A/B (aPTT ↑, PT normal); ITP (platelets ↓, PT/aPTT normal); warfarin overdose |
| Treatment — OPD | IM/SC vitamin K1 (phytomenadione) 10 mg; correct underlying cause; dietary sources: green leafy vegetables |
| Treatment — ICU | IV vitamin K 10 mg slow infusion (risk anaphylaxis — dilute, give slowly); Fresh Frozen Plasma (FFP) for immediate correction of acute bleeding (contains active clotting factors); 4-Factor PCC for life-threatening hemorrhage |
| Contraindications | IV vitamin K must be given slowly (risk of anaphylaxis); hemolysis in G6PD-deficient neonates at high doses; warfarin reversal with vitamin K takes 6–12 hours — use FFP/PCC for emergencies |
| Nutrition Clue | Newborns (sterile gut, no bacterial synthesis, low breast milk content); long-term antibiotics (kill gut bacteria); cholestyramine, cephalosporins, trimethoprim-sulfamethoxazole; cystic fibrosis; biliary disease; anorexia nervosa |
| Summary | Newborn prophylaxis is standard of care; parents declining IM K must be counseled — 81× higher risk of VKDB |
| Feature | Details |
|---|---|
| Disease Name | Vitamin D Toxicity |
| Age Group | Any; over-supplementation; neonates at risk |
| System | Renal, Cardiovascular, Neurological |
| Key Findings | Hypercalcemia: nausea, vomiting, polyuria, polydipsia, confusion, weakness, nephrolithiasis; band keratopathy; metastatic calcification; "stones, bones, groans, psychic moans" |
| Investigations | 25-OH vitamin D (↑ >150 ng/mL toxic); serum Ca (↑); 24-h urine Ca (↑); renal function; ECG (short QT) |
| Treatment — ICU | Stop vitamin D; IV 0.9% saline hydration; loop diuretics (furosemide); corticosteroids (if granulomatous cause); bisphosphonates; calcitonin; dialysis if severe |
| Summary | Fat-soluble = accumulates; always check 25-OH D before supplementing; routine high-dose supplementation not evidence-based |
| Feature | Details |
|---|---|
| Disease Name | Hypervitaminosis A; Isotretinoin embryopathy |
| Age Group | Any; special risk in pregnancy |
| System | Neurological (pseudotumor cerebri), Hepatic, Teratogenic, Skeletal |
| Key Findings | Acute: headache, vomiting, papilledema, desquamation; Chronic: alopecia, dry skin, bone/joint pain, hepatotoxicity, hyperlipidemia; Pregnancy: isotretinoin → microcephaly, cardiac defects, ear/eye abnormalities |
| Investigations | Serum retinol (>100 μg/dL = toxicity); liver enzymes (↑); lipid profile; ICP monitoring |
| Treatment | Stop vitamin A supplement; supportive; acetazolamide for raised ICP |
| Contraindications | Isotretinoin absolutely contraindicated in pregnancy (iPLEDGE program in USA) |
| Feature | Details |
|---|---|
| Disease Name | Niacin flushing; Hepatotoxicity; Pellagra-prevention vs lipid-lowering doses |
| Age Group | Adults on lipid-lowering therapy |
| Key Findings | Flushing (prostaglandin-mediated), pruritus, acanthosis nigricans-like skin darkening, hepatotoxicity (extended-release form), hyperglycemia, gout exacerbation |
| Treatment | Aspirin 325 mg 30 min before niacin dose reduces flushing; use immediate-release form for deficiency; switch to niacinamide for pellagra (no flushing) |
| Contraindications | Active liver disease, active peptic ulcer, gout, uncontrolled diabetes |
| Feature | Details |
|---|---|
| Disease Name | Sensory neuropathy from B6 excess |
| Age Group | Adults taking supplements >500 mg/day |
| System | Neurological (sensory ganglia) |
| Key Findings | Ataxia, burning hands/feet, impaired vibration/proprioception; motor function spared |
| Treatment | Stop B6; gradual recovery over months |
| Contraindications | Never exceed 200 mg/day without clinical indication |
| Feature | Details |
|---|---|
| Disease Name | Wernicke Encephalopathy → Korsakoff Psychosis |
| Age Group | Adults; alcoholism, prolonged vomiting, ICU patients |
| System | Neurological (limbic, diencephalic) |
| Key Findings | Wernicke triad: confusion + ataxia + ophthalmoplegia (nystagmus, lateral gaze palsy, 6th nerve palsy); Korsakoff: retrograde/anterograde amnesia + confabulation (irreversible in 80%) |
| Investigations | MRI: T2/FLAIR signal in mammillary bodies, thalami, periaqueductal grey; thiamine level; LFTs; ammonia; glucose |
| Treatment — ICU | Thiamine 500 mg IV TDS × 3 days BEFORE any glucose/dextrose (absolute priority); then IM thiamine; nutritional rehabilitation; magnesium (required cofactor for thiamine) |
| Contraindications | Glucose/dextrose without thiamine cover is iatrogenic Wernicke encephalopathy |
| Summary | Clinical diagnosis; MRI may be negative in early disease; treat empirically in any malnourished/alcohol-dependent patient presenting with altered mental status |
| Feature | Details |
|---|---|
| Disease Name | Acrodermatitis Enteropathica (zinc deficiency mimics vitamin deficiency pattern) |
| Age Group | Infants (weaning), adults with Crohn's/TPN |
| System | Mucocutaneous, GI, Immunological |
| Key Findings | Periorificial/acral dermatitis, alopecia, diarrhea, growth retardation; resembles biotin and B2 deficiency |
| Investigations | Serum zinc (↓); alkaline phosphatase (zinc-dependent enzyme, ↓); plasma zinc; urine zinc |
| Treatment | Zinc sulfate 0.5–1 mg/kg/day elemental zinc |
| Summary | Not a vitamin per se but clinically interdigitates with vitamin deficiency syndromes; included for differential completeness |
| Feature | Details |
|---|---|
| Disease Name | Renal osteodystrophy; Secondary Hyperparathyroidism |
| Age Group | Adults with CKD stage 3–5; dialysis patients |
| System | Renal, Endocrine, Musculoskeletal |
| Key Findings | Bone pain, fractures, ↑ PTH, hyperphosphatemia, hypocalcemia; pruritus; metastatic calcification; calciphylaxis (rare) |
| Investigations | 25-OH vitamin D; serum Ca, PO4, PTH; ALP; DEXA; X-ray (subperiosteal resorption at radial border of middle phalanges); renal function |
| Treatment | Active vitamin D: calcitriol 0.25 mcg/day or alfacalcidol; phosphate binders; dietary phosphate restriction; cinacalcet (calcimimetic) for refractory 2° hyperparathyroidism |
| Contraindications | Plain cholecalciferol less effective in CKD (impaired 1α-hydroxylation) — use calcitriol or alfacalcidol instead; avoid calcium-based binders if hypercalcemia |
| # | Vitamin | Disease | Body System | Key Blood Finding | Age Group | OPD Rx | ICU Alert |
|---|---|---|---|---|---|---|---|
| 1 | B1 Thiamine | Beriberi / Wernicke | Neuro/Cardiac | Normal CBC; ↑ lactate | All; alcoholics | Thiamine 100 mg/day | IV thiamine BEFORE glucose |
| 2 | B2 Riboflavin | Ariboflavinosis | Mucocutaneous | Normocytic anemia | Children; malnutrition | Riboflavin 5–10 mg/day | IV multivitamin |
| 3 | B3 Niacin | Pellagra (3 Ds) | Neuro/Skin/GI | Normocytic anemia | All; maize diet | Niacinamide 100 mg TDS | Niacinamide IV |
| 4 | B5 Pantothenate | Burning feet | Neuro/Metabolic | Normal | POW/severe malnutrition | 5–10 mg/day | In TPN |
| 5 | B6 Pyridoxine | Sideroblastic anemia; neuropathy | Neuro/Haem | Hypochromic microcytic + ring sideroblasts | All; INH users | 50–100 mg/day | 100 mg IV for seizures |
| 6 | B7 Biotin | Alopecia/dermatitis/metabolic acidosis | Skin/Neuro/Metabolic | ↑ lactate, ↑ ammonia | Infants (biotinidase); raw egg diet | Biotin 5–10 mg/day | IM/IV biotin |
| 7 | B9 Folate | Megaloblastic anemia; NTD | Haem/Neuro (fetal) | Macrocytic anemia; hyperseg neutrophils; thrombocytopenia | Pregnant women; elderly; alcoholics | Folic acid 5 mg/day | IV folic acid; check B12 first |
| 8 | B12 Cobalamin | Pernicious anemia; SCD spine | Haem/Neuro | Macrocytic anemia; hyperseg neutrophils; ↑ MMA | >50 yrs; vegans; post-gastrectomy | IM hydroxocobalamin 3-monthly | IM B12 daily; neuro monitoring |
| 9 | C Ascorbic acid | Scurvy (4 Hs) | Vascular/Skin/Haem | Normocytic anemia; normal PT/platelets | Elderly males; autistic children; dialysis | Ascorbic acid 1 g/day × 1 wk | IV vitamin C |
| 10 | A Retinol | Night blindness; xerophthalmia | Ophthalmologic/Immune | Normocytic anemia; lymphopenia | Children (WHO #1 preventable blindness) | Vitamin A 200,000 IU × 3 doses | IV vitamin A |
| 11 | D Calciferol | Rickets; osteomalacia | Musculoskeletal/Endocrine | ↓ Ca, ↓ PO4, ↑ ALP, ↑ PTH | Infants; elderly; CKD | D3 800–2000 IU/day | IV calcium gluconate for tetany |
| 12 | E Tocopherol | Spinocerebellar ataxia; hemolytic anemia (neonates) | Neurological/Haem | Hemolytic anemia (premature infants); acanthocytes | Fat malabsorption; premature neonates | Alpha-tocopherol 400–800 IU/day | Parenteral E in TPN |
| 13 | K Phylloquinone | VKDB; hemorrhagic disease newborn | Coagulation | ↑ PT/INR; ↑ aPTT; normal platelets | Newborns; antibiotic users | IM K1 10 mg | IV K1 + FFP/PCC for active bleeding |
| Finding | Vitamin Deficiency |
|---|---|
| Macrocytic anemia + hypersegmented neutrophils | B9 (Folate), B12 |
| Microcytic/hypochromic + ring sideroblasts | B6 (Pyridoxine) |
| Normocytic anemia | B1, B2, B3, C, A |
| Hemolytic anemia + acanthocytes | Vitamin E (especially premature neonates) |
| Normal platelets + ↑ PT/INR | Vitamin K deficiency |
| Thrombocytopenia | Severe B9/B12 (pancytopenia) |
| ↑ MMA + homocysteine | B12 |
| ↑ Homocysteine alone | B9 (Folate) or B6 |
| Lactic acidosis | B1 (thiamine), B7 (biotin) |
| ↓ Ca, ↓ PO4, ↑ ALP, ↑ PTH | Vitamin D |
Megaloblastic anemia (macrocytic)
├── + Neurological (SCD, proprioception loss) → B12 deficiency
├── + Neural tube defect in fetus (no neuro in adult) → Folate deficiency
└── + Drug (MTX, hydroxyurea, TMP) → Drug-induced megaloblastosis
Peripheral neuropathy
├── + Alcoholism + confusion + ophthalmoplegia → B1 (Wernicke)
├── + Ataxia + areflexia + fat malabsorption → Vitamin E
├── + Isoniazid use + sideroblastic anemia → B6
└── + Posterior column degeneration → B12
Mucocutaneous rash (photosensitive)
├── Symmetrical, sun-exposed + diarrhea + dementia → B3 (Pellagra)
├── Angular stomatitis + scrotal dermatitis → B2
└── Perifollicular petechiae + corkscrew hairs → Vitamin C (Scurvy)
Bone pain + fractures
├── Children + bow legs + rachitic rosary → Vitamin D (Rickets)
├── Adults + Looser zones on X-ray → Vitamin D (Osteomalacia)
└── Children + subperiosteal hemorrhage + normal PT → Vitamin C (Scurvy)
Bleeding (PT/INR ↑, platelets normal)
└── Vitamin K deficiency (vs DIC: no thrombocytopenia; vs hemophilia: PT ↑ not just aPTT)
Blindness/night blindness
├── Children in developing world → Vitamin A
└── + Ataxia + family history → AVED (Vitamin E deficiency, TTPA mutation)
| Scenario | Action |
|---|---|
| Any malnourished/alcoholic patient requiring IV fluids/dextrose | Give thiamine 500 mg IV TDS BEFORE glucose — prevents Wernicke |
| Altered mental status + ataxia + eye signs | Empiric IV thiamine immediately — do NOT wait for levels |
| Neonatal intracranial hemorrhage with normal platelets | Check vitamin K status; give IM K immediately |
| Megaloblastic anemia before starting folate | Always check B12 first — folate alone will worsen B12 neuropathy |
| Patient on INH/anti-TB therapy | Co-prescribe pyridoxine 25–50 mg/day from day 1 |
| High-dose biotin supplementation before cardiac enzymes (troponin) | Stop biotin 48–72 h before lab testing — causes falsely normal troponin |
| Post-bariatric surgery patient in ICU | Screen for B1, B12, D, iron, folate, zinc, copper |
sleeping disorder all ages group disease treatment investigation finding differential diagnosis contraindications ICU and OPD and blood RBC WBC platelet nutrition flute of diagnosis summary